Dara L. Aisner
University of Colorado Cancer Center · 331 works · 22,805 citations · h-index 71
Top works
- Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer
- Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
- Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer
- The Learning Healthcare System: Workshop Summary
- Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
- Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
- Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
- Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer
- An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101
- Functional requirement of p23 and Hsp90 in telomerase complexes
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
- Non–Small Cell Lung Cancer, Version 4.2024
- Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience
- Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation
- Oncogene status predicts patterns of metastatic spread in treatment‐naive nonsmall cell lung cancer
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018
- NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023